HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 1,405-1,416 of 4,505
Other study type icon
CompletedNCT02009826

Psychosis-Associated Neuroinflammation in Schizophrenia

Official study title

Phase 0 Clinical Protocol: A Longitudinal and Multimodal Exploratory Study to Evaluate a Neuroinflammatory Hypothesis in Patients With Schizophrenia Compared to Young Healthy Subjects

This study has finished and is no longer accepting participants.

Multiple locations, including Boechout
SchizophreniaObservational studyAges 18–40
Countries
Belgium
Sponsor
Universiteit Antwerpen
Drug study icon
Active Not RecruitingNCT05333003

Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity

Official study title

Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity for Metformin Non-responders: a Single-blind Randomized Control Trial

This study is no longer accepting new participants.

In Toronto
SchizophreniaMedication studyAges 18–70
Countries
Canada
Sponsor
Centre for Addiction and Mental Health (Hospital / academic medical center)
Drug study icon
WithdrawnNCT03994965

The Sub-Sero Study

Official study title

Identification of a Serotonin 2A Receptor Subtype of Schizophrenia Spectrum Disorders With Pimavanserin: The Sub-Sero Proof-of-principle Study

This study was withdrawn before enrollment.

Location not clearly listed
SchizophreniaMedication studyAges 18–45
Countries
Sponsor
Bjorn H. Ebdrup
Drug study icon
CompletedNCT01364792

To Rescue Cognition With Valaciclovir

Official study title

A Double Blind Placebo Controlled Study of Valaciclovir in Treatment of Psychosis in Patients With Schizophrenia

This study has finished and is no longer accepting participants.

In Groningen
SchizophreniaMedication studyAges 18+
Countries
Netherlands
Sponsor
University Medical Center Groningen
Other study type icon
Active Not RecruitingNCT03442101

Trajectories of Treatment Response as Window Into the Heterogeneity of Psychosis: a Longitudinal Multimodal Imaging Study

Official study title

Trajectories of Treatment Response as Window Into the Heterogeneity of Psychosis: a Longitudinal Multimodal Imaging Study in Medication-naïve First Episode Psychosis Patients

This study is no longer accepting new participants.

In Birmingham
SchizophreniaObservational studyAges 17–35
Countries
United States
Sponsor
University of Alabama at Birmingham
Other study type icon
CompletedNCT06043206

Bariatric Surgery in people with Schizophrenia

Official study title

Bariatric Surgery in Patients With Schizophrenia

This study has finished and is no longer accepting participants.

In Barcelona
SchizophreniaObservational study
Countries
Spain
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Behavioral study icon
CompletedNCT05500651

Dance and Movement Therapy in people with Schizophrenia

Official study title

The Effect of Dance and Movement Therapy as a Group Work Technique on Negative Symptoms and Disability in Patients With Schizophrenia

This study has finished and is no longer accepting participants.

In Amasya
SchizophreniaInterventional study
Countries
Türkiye
Sponsor
Amasya University
Behavioral study icon
CompletedACTRN12620001309976

Investigating resistance training in people living with psychotic disorders.

Official study title

Resistance training versus aerobic interval training in a rehabilitation setting for people living with psychotic disorders: a randomised controllled trial

This study has finished and is no longer accepting participants.

Multiple locations, including Woolloongabba
SchizophreniaInterventional studyAges 18–64
Countries
Australia
Sponsor
Dr Nicole Korman

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.